The role of α-klotho in human cancer: molecular and clinical aspects.

Hagai Ligumsky, Keren Merenbakh-Lamin, Noa Keren-Khadmy, Ido Wolf, Tami Rubinek

Journal: Oncogene 2022;41(40):4487-4497

PMID: 36038662

Abstract

Klotho is a well-established longevity hormone. Its most prominent function is the regulation of phosphate homeostasis. However, klotho possesses multiple pleiotropic activities, including inhibition of major signaling pathways, reducing oxidative stress and suppressing inflammation. These activities are tightly associated with cancer, and klotho was discovered as a universal tumor suppressor. We review here novel molecular aspects of klotho activity in cancer, focusing on its structure-function relationships and clinical aspects regarding its expression, blood levels, clinical risk, and prognostic value in the clinical setting. In addition, the potential benefit of klotho treatment combined with chemotherapy, biological therapy, or immunotherapy, are discussed. Finally, as klotho was shown in preclinical models to inhibit cancer development and growth, we discuss various approaches to developing klotho-based therapies.

© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Address: Oncology Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.; Oncology Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. [email protected].; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. [email protected].

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.